Ortho-Clinical Diagnostics
Wales Doing business as Lifescan Part of Quidelortho Corporation
- UEI
- TNK7XV5KG5T3
- CAGE
- U7254
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- International Organization
- Corporate family
-
-
Parent
San Diego, CA
JH9UWAVVFJK1
-
Parent
San Diego, CA
JH9UWAVVFJK1
- SAM.gov registration date
- Physical address
- Felindre Meadows, Bridgend CF35 5PZ, UK
- Website
- quidelortho.com
- Founded
- 1979
- Employees
- 5K-10K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $346,570 |
| FY2025 | $451,102 |
| FY2024 | $230,965 |
| FY2023 | $365,191 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $346,570 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Sysmex UK LIMITED | Wymbush, England | 423490 Other Professional Equipment and Supplies Merchant Wholesalers |
| Bio Rad Laboratories Inc. | Hercules, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Luminex Corp | Austin, TX | 325413 In-Vitro Diagnostic Substance Manufacturing |
| US Customer Operations | Brea, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Grifols Diagnostic Solutions Inc. | Emeryville, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
About the company
Ortho-Clinical Diagnostics, doing business as Lifescan, a United Kingdom-based manufacturer of in vitro diagnostic equipment and clinical chemistry analyzers, operates as a prime contractor supplying diagnostic reagents, analyzers, and related consumables to the U.S. Department of Defense, predominantly through a single-award indefinite delivery vehicle with United States Air Forces in Europe and Africa. The vendor is a child entity of Quidelortho Corporation, a San Diego-based for-profit manufacturer and the parent holding federal prime contracting authority.
Ortho-Clinical Diagnostics competes exclusively on full-and-open contracts with no set-aside designations across its federal footprint. The vendor's capability portfolio centers on clinical chemistry analyzers, diagnostic reagents, maintenance and warranty services, and consumables for military laboratory operations. Representative work includes a $78,547 delivery order from USAFE-AFAFRICA in August 2023 for clinical chemistry analyzer reagents; a $72,881 delivery order in July 2023 for the lease of two clinical chemistry analyzers with external support equipment and technical training; and a $36,088 delivery order from the Defense Health Agency in July 2025 for gel testing reagents and consumables. Monthly reagent orders typically range from $2,500 to $33,000, reflecting the high-volume consumable requirements characteristic of military laboratory operations.
Customer concentration is extreme: USAFE-AFAFRICA accounts for 138 awards valued at $11.3 million (76% of combined potential value), while the Defense Health Agency anchors 22 awards at $3.2 million. These two agencies account for 100% of meaningful dollar volume. The Air Force Finance and Accounting Service places 39 awards but carries only $358 thousand in combined potential value, representing small transactional orders. The Department of the Navy holds one award of nominal value.
Ortho-Clinical Diagnostics holds three primary parent vehicles: Indefinite Delivery Contract FA558723D0001 with 41 task orders valued at $3.6 million (the July 1, 2023 award cited in detailed summaries, with ceiling of $5.2 million and ordering period through June 30, 2028); Indefinite Delivery Contract FA558717D0002 with 85 task orders at $1.6 million; and Indefinite Delivery Contract FA558706A0009 with 67 task orders at $505 thousand. All three vehicles support diagnostic supply to the 48th Medical Group at RAF Lakenheath. Performance is conducted entirely in Great Britain, United Kingdom.
Activity has remained stable but lightweight year over year—eighteen awards in 2022, thirteen in 2023, seventeen in 2024, fourteen in 2025, and five through March 2026—with combined potential value of $14.9 million across 207 awards since 1994. Thirteen awards (combined potential value $405 thousand) complete within the next twenty-four months, representing modest recompete exposure. The vendor obligates approximately 43% of potential value, with obligated dollars at $6.4 million against the $14.9 million ceiling. Ortho-Clinical Diagnostics operates without identified subcontractors, positioning itself as the exclusive sourcing partner for the specified diagnostic platform and consumables to U.S. military medical treatment facilities in the European theater. The two highest NAICS categories are Surgical and Medical Instrument Manufacturing (129 awards) and In-Vitro Diagnostic Substance Manufacturing (74 awards), with the top PSC code being In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (153 awards).
Quick answers
Is Ortho-Clinical Diagnostics registered in SAM.gov?
Yes. Ortho-Clinical Diagnostics's SAM.gov registration is active through June 25, 2027.
How much has Ortho-Clinical Diagnostics received in federal contracts?
Federal contracts obligated $451,102 to Ortho-Clinical Diagnostics in fiscal year 2025 and $1,393,828 in fiscal years 2023 through 2027.
How does Ortho-Clinical Diagnostics rank among federal contractors?
Ortho-Clinical Diagnostics ranked #6 in PSC 6550, #7 in NAICS 325413 and #54 in NAICS 3254 in FY2025.
What is Ortho-Clinical Diagnostics's most recent federal award?
Ortho-Clinical Diagnostics's most recent federal contract award is 48 MDG: emergency reagents order (FA558726F0120), from Air Forces Europe and Africa (USAF), on July 23, 2026.
On GovTribe
See Ortho-Clinical Diagnostics's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors